524.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
United Therapeutics Corp Borsa (UTHR) Ultime notizie
United Therapeutics director Tommy G Thompson sells $1.1m in stock - Investing.com Canada
United Therapeutics director Tommy G Thompson sells $1.1m in stock By Investing.com - Investing.com South Africa
Rothblatt, United Therapeutics CEO, sells $5.1m in UTHR stock - Investing.com
Rothblatt, United Therapeutics CEO, sells $5m in stock By Investing.com - Investing.com Australia
Rothblatt, United Therapeutics CEO, sells $5m in stock - Investing.com
United Therapeutics stock hits all-time high at 548.43 USD - Investing.com
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares of Stock - MarketBeat
United Therapeutics stock surges 32% in 6 months: Here's why - MSN
Insider Sell: Judy Olian Sells Shares of United Therapeutics Cor - GuruFocus
Rothblatt of United Therapeutics sells $5m in UTHR stock - Investing.com
United Therapeutics CFO Edgemond sells $5.27 million in UTHR stock - Investing.com
Therapeutics Stocks Q4 In Review: United Therapeutics (NASDAQ:UTHR) Vs Peers - TradingView
Rothblatt, United Therapeutics CEO, sells $4.9m in UTHR stock By Investing.com - Investing.com India
Rothblatt, United Therapeutics CEO, sells $4.9m in UTHR stock - Investing.com
[144] UNITED THERAPEUTICS Corp SE... | UTHR SEC FilingForm 144 - Stock Titan
United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares under 10b5-1 plan - stocktitan.net
UTHR (UTHR): Judy Olian to sell 200 shares under Form 144 notice - Stock Titan
Pulmonary Arterial Hypertension Market: Expanding Revenue Landscape to 2034 – DelveInsight | Merck, Janssen Pharma, Aerovate Therapeutics, Novartis, Insmed Inc, Chugai Pharma, Keros Therapeutics - Barchart
UTHR: Wells Fargo Raises Price Target for United Therapeutics | UTHR Stock News - GuruFocus
Dip Buying: Can United Therapeutics Corporation grow without dilution2026 Intraday Action & Verified Stock Trade Ideas - baoquankhu1.vn
If You Invested $1,000 in United Therapeutics Corp. (UTHR) - stocktitan.net
Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Expands as 80+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart
United Therapeutics CEO Rothblatt sells $5m in UTHR stock - Investing.com UK
United Therapeutics CEO Rothblatt sells $5m in UTHR stock By Investing.com - Investing.com South Africa
Paul Mahon Sells 8,300 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics (UTHR) CEO exercises options and sells 9,500 shares under plan - Stock Titan
United Therapeutics (UTHR) EVP sells 8,300 shares after option exercise - Stock Titan
UTHR affiliate to sell 8,300 shares via option exercise (NASDAQ: UTHR) - Stock Titan
United Therapeutics (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan
Biotech Stocks Worth WatchingMarch 18th - MarketBeat
MannKind: Strategic Uncertainty Follows United Therapeutics' Pivot (Rating Downgrade) - Seeking Alpha
Insider Sell: Jan Malcolm Sells Shares of United Therapeutics Co - GuruFocus
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 9,500 Shares - TradingView
United Therapeutics (UTHR) COO exercises RSUs; 14,706 shares withheld for taxes - Stock Titan
United Therapeutics (UTHR) CFO exercises RSUs, shares withheld for taxes - Stock Titan
United Therapeutics (UTHR) legal chief vests 16,691 RSUs, nets 45,172 shares - stocktitan.net
United Therapeutics (UTHR) CEO settles 69,579 RSUs with tax withholding - stocktitan.net
United Therapeutics (UTHR) director sells 45 shares under 10b5-1 plan - Stock Titan
United Therapeutics Corporation $UTHR Holdings Lifted by L2 Asset Management LLC - MarketBeat
Assessing United Therapeutics (UTHR) Valuation After TETON-2 Tyvaso Data And New US$2b Buyback Program - simplywall.st
Rothblatt of United Therapeutics sells $5.1 million in UTHR stock - Investing.com
Judy Olian sells 400 UTHR shares across March transactions (UTHR) - Stock Titan
United Therapeutics CEO Martine A. Rothblatt Executes Stock Sales - TradingView
United Therapeutics (UTHR) director sells 200 shares under 10b5-1 plan - Stock Titan
United Therapeutics (UTHR) CEO pre-planned option exercise and 9,500-share sale - Stock Titan
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 8,984 Shares - MarketBeat
United Therapeutics (NASDAQ:UTHR) CEO Sells $276,054.84 in Stock - MarketBeat
Why United Therapeutics Catapulted 33%, Pulling Insmed, Liquidia With It - MSN
United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares - Stock Titan
Tyvaso IPF Data In NEJM Reframes United Therapeutics Growth Potential - Yahoo Finance
United Therapeutics Stock Surges 32% in 6 Months: Here's Why - TradingView
Van ECK Associates Corp Purchases 29,297 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Korea Investment CORP Has $5.90 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Shares Jump 32% Over Six Months: The Reasons Explained - Bitget
UBS raises United Therapeutics stock price target to $705 on catalysts - Investing.com Nigeria
Cantor Fitzgerald raises United Therapeutics stock price target to $625 - Investing.com Nigeria
Cantor Fitzgerald raises United Therapeutics stock price target to $625 By Investing.com - Investing.com India
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):